首页> 外国专利> Cholinesterase determn. in plasma or erythrocyte samples - based on conversion of radio-labelled acetyl-choline in undiluted samples

Cholinesterase determn. in plasma or erythrocyte samples - based on conversion of radio-labelled acetyl-choline in undiluted samples

机译:胆碱酯酶确定。血浆或红细胞样品中的血浆-基于未稀释样品中放射性标记的乙酰胆碱的转化

摘要

Determn. of cholinesterase activity in undiluted plasma and erythrocyte samples is effected by (a) incubating the sample with (14C-acetyl)choline at 25 deg.C. and pH 7.4; (b) adding EtOH/HOAc to stop the reaction; (c) evaporating off any 14C-acetic acid formed; (d) measuring the difference in radioactivity between the evapd. material and residue; and (e) calculating the cholinesterase activity (in miromole/min.ml) from the radioactivity difference, the specific radioactivity of the (14C-acetyl)choline, the incubation time and the sample vol.. The sample vol. is 0.1 ml. For determn. of butyrylcholinesterase in plasma samples, the substrate concn. is 9.1 mM. For determn. of acetylcholinesterase in erythrocyte samples, the substrate concn. is 3.6 mM. USE/ADVANTAGE - The process is useful for monitoring the therapy of Alzheimer's disease using reversible cholinesterase inhibitors. Errors due to sample dilution are eliminated.
机译:确定。未稀释的血浆和红细胞样品中胆碱酯酶活性的测定是通过(a)将样品与(14C-乙酰基)胆碱在25℃下孵育而实现的。和pH 7.4; (b)添加EtOH / HOAc以终止反应; (c)蒸发掉形成的任何14C-乙酸; (d)测量蒸发之间的放射性差异。材料和残留物; (e)从放射性差异,(14C-乙酰基)胆碱的比放射性,温育时间和样品体积计算胆碱酯酶活性(以miromole / min.ml计)。是0.1毫升。确定。血浆样品中丁酰胆碱酯酶的浓度,底物浓度是9.1毫米。确定。样品中乙酰胆碱酯酶的含量,底物浓度是3.6毫米。使用/优势-该过程可用于监测使用可逆胆碱酯酶抑制剂对阿尔茨海默氏病的治疗。消除了由于样品稀释引起的误差。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号